PANACEABIO — Panacea Biotec Share News
0.000.00%
Last trade - 00:00- IN₹19.08bn
- IN₹17.91bn
- IN₹6.40bn
India's Panacea Biotec hits upper circuit on contracts worth $127 mln
Brief: Panacea Biotec Gets Awards Worth US$ 127.30 Million From Unicef And Pan American Health Organization
Brief: Panacea Biotec Says Unit Received USFDA Indicating Inspection Classification As "Official Action Indicated"
Brief: India's Panacea Biotec Ltd June-Quarter Consol Net Loss After Tax Narrows
India's Panacea Biotec rises on deal with Mankind Pharma
Brief: Mankind Pharma Acquires Panacea Biotec’s Domestic Formulation Brands For India And Nepal
Brief: CEPI, THSTI, Panacea Biotec Partner To Develop Broadly Protective Betacoronavirus Vaccines
Brief: India's Panacea Biotec Dec-Qtr Consol Net Loss Widens
Brief: Panacea Biotec Says To Consider Proposal Of Raising Funds
India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal
Brief: Panacea Biotec To Make Up To 25 Mln Doses Of Sputnik V Vaccine
India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine
Brief: Panacea Biotec June Quarter Consol Net Loss After Tax Widens
Indian shares close at near record levels on financial boost, vaccine availability
Indian shares hover near peaks on vaccination, earnings hopes
India's Panacea Biotec jumps 9% on manufacturing licence for Sputnik V vaccine
Brief: Panacea Biotec Says Receipt Of Manufacturing License for Sputnik V Vaccine
India's Serum Institute seeks approval to make Russia's Sputnik V vaccine - sources (updated)
Brief: Panacea Biotec Says To Consider Raising Of Funds